Larvol Delta - Cannabics-Pharmaceuticals-to-Initiate-invivo-Dose-Response-Study-on-Proprietary-Colorectal-Cancer-Drug-Candidate-RCC33

Cannabics RCC-33 - Cannabics

https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-to-initiate-in-vivo-dose-response-study-on-proprietary-colorectal-cancer-drug-candidate-rcc-33-301259607.html

Mar 31, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next